Usage of human stem cells in experimental ischemic disorders
- Authors: Surkov K.G.1,2,3, Belova L.A.1,2,3, Krasnyakov V.K.1,2,3, Karpova N.S.1,2,3
-
Affiliations:
- All-Russian Scientific Center for the Safety of Biologically Active Substances
- St. Petersburg State Healthcare Institution "City Blood Transfusion Station"
- Closed Joint Stock Company "Crionix"
- Issue: Vol 2, No 2 (2007)
- Pages: 93-93
- Section: Reports
- URL: https://genescells.ru/2313-1829/article/view/233502
- ID: 233502
Cite item
Open Access
Access granted
Full Text
About the authors
K. G. Surkov
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation, Kupavna Old; Saint Petersburg; Saint Petersburg
L. A. Belova
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Email: redaktor@celltranspl.ru
Russian Federation, Kupavna Old; Saint Petersburg; Saint Petersburg
V. K. Krasnyakov
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Email: redaktor@celltranspl.ru
Russian Federation, Kupavna Old; Saint Petersburg; Saint Petersburg
N. S. Karpova
All-Russian Scientific Center for the Safety of Biologically Active Substances; St. Petersburg State Healthcare Institution "City Blood Transfusion Station"; Closed Joint Stock Company "Crionix"
Email: redaktor@celltranspl.ru
Russian Federation, Kupavna Old; Saint Petersburg; Saint Petersburg
References
Supplementary files
